With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
The role of a Talent Acquisition Specialist is to partner with the hiring team and is, therefore, an influential and critical one. The role is responsible for building a pipeline of potential talent for a group of departments. This is a full-cycle recruitment role, therefore you will need to rapidly identify, attract and screen potential candidates for a wide variety of vacancies, as well as interview and manage the offer to hire process at all levels of seniority, and with candidates based world-wide. The candidate experience we offer at BenevolentAI is hugely important and so a positive, helpful and can-do attitude, as well as impeccable written and verbal communication skills, are a must.
This will involve being very proactive, developing and executing sourcing plans, building talent pipelines, conducting direct sourcing activity, research, screening, interviewing, pre-selecting, offer management and managing the hiring administration process.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the apply button and join us.
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
Our team will only contact you from the domain @benevolent.ai. If you receive a suspicious contact request, please email firstname.lastname@example.org. Thank you.